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Abstract
Background: We have previously shown that approximately 25% of those with asthma in West Sweden have
multiple asthma symptoms, which may describe a group of patients with more severe disease. Furthermore,
asthma is associated with several co-morbid diseases, including rhinitis and chronic rhinosinusitis. The aim of this
study was to determine whether multi-symptom asthma is related to signs of severe asthma, and to investigate
the association between multi-symptom asthma and different symptoms of allergic and chronic rhinosinusitis.
Methods: This study analyzed data on asthma symptoms, rhinitis, and chronic rhinosinusitis from the 2008 West
Sweden Asthma Study, which is an epidemiologically based study using the OLIN and GA
2LEN respiratory and
allergy focused questionnaires.
Results: Multi-symptom asthma was present in 2.1% of the general population. Subjects with multi-symptom
asthma had more than double the risk of having night-time awakenings caused by asthma compared with those
with fewer asthma symptoms (P < 0.001). The prevalence of allergic rhinitis was similar in the fewer- and multi-
symptom asthma groups, but nasal blockage and rhinorrhea were significantly increased in those with multi-
versus fewer-symptom asthma (odds ratio 2.21; 95% confidence interval 1.64-2.97, versus 1.49; 1.10-2.02,
respectively). Having any, or one to four symptoms of chronic rhinosinusitis significantly increased the risk of
having multi- versus fewer-symptom asthma (P < 0.01).
Conclusion: An epidemiologically identified group of individuals with multiple asthma symptoms harbour to
greater extent those with signs of severe asthma. The degree of rhinitis, described by the presence of symptoms of
nasal blockage or rhinorrhea, as well as the presence of any or several signs of chronic rhinosinusitis, significantly
increases the risk of having multi-symptom asthma.
Background
Asthma is a common chronic disease with a prevalence
of approximately 5-10% in different populations [1-6].
We have recently shown that the prevalence of asthma
in West Sweden is approximately 8.5%, based on a large
epidemiological survey [6]. Importantly, our data argue
that there has been no further increase in the prevalence
of asthma over the last 18 years in this part of Europe,
and moreover that the overall degree of airway
symptoms have decreased over this period [6]. However,
in the current survey we identify a large population of
individuals with multiple asthma symptoms, which
amounts to approximately 25% of all asthmatics, and 2%
of the general population [6].
Asthma is associated with several co-morbid diseases,
including rhinitis and chronic rhino-sinusitis. Several stu-
dies have shown a relationship between nasal symptoms
and asthma, and rhinitis is identified as an important risk
factor of developing asthma [7-10]. Furthermore, studies
that have recruited asthma patients from different clinical
cohorts have shown that severity of nasal symptoms is
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any medium, provided the original work is properly cited.associated with severity and difficulty to treat the asthma
[9,11-16]. Despite these findings, no epidemiological stu-
dies have described the relationship between different
nasal symptoms and asthma symptoms in a large random
population sample. Furthermore, multi-symptom asthma,
identifiable by epidemiological means, has not been
described previously.
T h ea i mo ft h ec u r r e n ts t u d yw a st od e t e r m i n e
whether multi-symptom asthma is related to signs of
severe asthma, and to describe the association between
multi-symptom asthma and different symptoms of nasal
disease in a general population. In particular, we investi-
gate the relationship between multi-symptom asthma
and symptoms of chronic rhinosinusitis, defined as nasal
symptoms ongoing beyond 12 weeks a year.
Methods
Study population and participation
The study population has been described previously [6].
Briefly, in 2008 a folder containing two questionnaires
was mailed out to 30,000 randomly selected subjects,
aged 16-75, living in the West of Sweden; 15,000 sub-
jects lived in the urban area of Gothenburg and 15,000
in the remaining region of West Sweden. 29 218 could
be traced. The total response rate after three reminders
was 62%, and the final study sample consisted of 18 067
subjects. A non-response study performed showed no
differences in prevalence of symptoms or disease
between responders and non-responders [17].
Questionnaire
The questionnaires used in the study have been
described in detail elsewhere [6]. In brief, the folder
contained two questionnaires: 1) the Swedish Obstruc-
tive Lung Diseases in Northern Sweden (OLIN) ques-
tionnaire [18] with additional questions on work and
housing conditions; and 2) the Swedish version of the
Global Allergy and Asthma European Network
(GA
2LEN) questionnaire [6]. The questionnaires con-
tained questions on asthma, allergic rhinitis, respiratory
and nasal symptoms, use of asthma medication, and
possible determinants of the disease.
Definitions
The definitions in this manuscript are based on the fol-
lowing questions:
Physician-diagnosed asthma: “Have you been diag-
nosed as having asthma by a doctor?"; Asthma medica-
tion: “Do you currently use asthma medicine
(continuously or as needed)?"; Attacks of shortness of
breath: “Do you presently have, or have you had in the
last 10 years, asthma symptoms (intermittent breathless-
ness or attacks of shortness of breath; the symptoms
may exist simultaneously with or without cough or
wheezing)?” and “Have you had these symptoms within
the last year?"; Any wheeze: “Have you had whistling or
wheezing in the chest at any occasion during the last 12
months?"; Recurrent wheeze: “Do you usually have
wheezing or whistling in your chest when breathing?";
Dyspnea: “Do you get breathless when you walk on level
ground with people of your own age?"; Breathlessness-
exertion: “Do you usually have breathlessness, wheeze or
severe cough on exertion?"; Breathlessness-cold: “Do you
usually have breathlessness, wheeze or severe cough in
cold weather?"; Breathlessness-exertion in cold: “Do you
usually have breathlessness, wheeze or severe cough on
exertion in cold weather?"; Allergic rhinitis: “Have you
now, or have you ever had, allergic rhinitis (hay-fever)
or allergic eye catarrh?"; Nasal blockage: “Do you have
n a s a lb l o c k a g em o r eo rl e s sc o n s t a n t l y ? " ;Rhinorrhea:
“Do you have a runny nose more or less constantly?";
Family history of asthma: “Do any of your parents or
sibling have, or have had, asthma?"; Family history of
allergy: “Do any of your parents or sibling have, or have
had, allergic rhinitis or allergic eye catarrh?"; Occupa-
tional exposure: “Have you been heavily exposed to gas,
dust or fumes at work?"; Waking-cough: “Have you been
woken by an attack of coughing at any time in the last
12 months?"; Waking-up with shortness of breath: “Have
you been woken by an attack of shortness of breath at
any time in the last 12 months?"; Waking-tight chest:
“Have you woken up with tightness in your chest at any
time during the last 12 months?"; Physician diagnosed
chronic sinusitis: “Has a doctor ever told you that you
have chronic sinusitis?"; Nasal blockage, at least 12
weeks; “Has your nose been blocked for more than 12
weeks during the last 12 months?”.
Definition of multi-symptom asthma
To be considered having multi-symptom asthma, a sub-
ject was required to report physician-diagnosed asthma
and asthma medication and attacks of shortness of
breath and recurrent wheeze and at least one out of any
wheeze, dyspnoea, breathlessness-exertion, breathlessness-
cold and breathlessness-exertion in cold.
For the purpose of this paper all subjects reporting
physician-diagnosed asthma and not fulfilling the
requirements of multi-symptom asthma are referred to
as having fewer-symptom asthma.
Ethical approval
The regional ethic committee in West Sweden approved
the study.
Analyses
Statistical analyses were performed using SPSS version
16.0. Comparisons of proportions were tested with a
chi-square test or Fisher’s exact test. A P-value of <0.05
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in multiple logistic regression analyses were: family his-
tory of asthma and/or allergy, smoking habits, age, occu-
pational exposure to gas, dust or fumes, and gender. In
addition to these covariates, allergic rhinitis, blocked
nose, and runny nose were added one by one and all
together. Odds ratios (OR) with 95% confidence inter-
vals (CI) are reported. Logistic regression models were
performed in three combinations: non-asthma versus
fewer-symptom asthma, non-asthma versus multi-symp-
tom asthma and fewer-symptom asthma versus multi-
symptom asthma.
Results
Relationship between multi-symptom asthma and night-
time asthma symptoms
The subjects that reported multi-symptom asthma (2.1%
of the whole population) had a high risk of having
night-time awakenings due to chest-tightness, shortness
of breath or cough compared with both the populations
without asthma and fewer-symptom asthma (P < 0.001,
Figure 1).
Prevalence of allergic rhinitis, nasal blockage and
rhinorrhea
Reported allergic rhinitis (AR) was more prevalent
among subjects with fewer-symptom asthma (64.4%)
and multi-symptom asthma (65.7%) compared with sub-
jects without asthma (22.9%; P < 0.001 in both cases,
Table 1). There was no significant difference in the pre-
valence of reported allergic rhinitis between the popula-
tions with fewer-symptom asthma versus the population
with multi-symptom asthma (Table 1).
The prevalence of reported nasal blockage and rhinor-
rhea was higher in the group with multi-symptom
asthma compared with the fewer-symptom asthma
group (Table 1). Reports of any nasal symptom (AR,
nasal blockage or rhinorrhea) occurred in 81.7% of the
multi-symptom asthma group, 74.0% of the fewer-symp-
tom asthma group, and 33.3% of the non-asthma popu-
lation (Table 1). The frequency of nasal symptoms in
the non-asthma, fewer-symptom asthma, and multi-
symptom asthma groups are shown Figure 2. The preva-
lence of all three nasal symptoms was higher in subjects
with multi-symptom asthma (P < 0.01; Figure 2).
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Figure 1 Prevalence of waking up with tight chest, shortness of breath or cough, during the last 12 months, in the non-asthma,
fewer-symptom asthma or multi-symptom asthma groups. Subjects with multi-symptom asthma had a higher risk of waking up at night
regardless of which respiratory symptom is analyzed. Blue: non-asthma, maroon, fewer-symptom asthma and green: multi-symptom asthma. ***
P < 0.001.
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multi-symptom asthma
Nasal blockage and rhinorrhea were strong risk factors
for multi-symptom asthma compared with fewer-symp-
t o ma s t h m a( O R2 . 6 8a n d2 . 2 4 ,r e s p e c t i v e l y ;F i g u r e3 )
while reports of allergic rhinitis were not associated with
an increased risk of having multi-symptom asthma versus
fewer-symptom asthma. In a multiple logistic regression
analysis, nasal blockage and rhinorrhea remained statisti-
cally significant risk factors, however, with slightly lower
ORs (Table 2). Additional risk factors for multi-symptom
asthma compared with fewer-symptom asthma in the
multiple logistic regression model were: family history of
allergy, family history of combined asthma and allergy,
old age (> 60 years), occupational exposure to gas, dust
or fumes, and female gender (Table 2). In the multiple
regression models, comparing multi-symptom asthma
and fewer-symptom asthma with non-asthma, AR was
the strongest risk factor for fewer-symptom asthma (OR
5.0) and multi-symptom asthma (OR 3.7; Table 2) versus
no asthma. Nasal blockage and rhinorrhea were also sig-
nificant risk factors in these models (Table 2).
Symptoms of chronic rhinosinusitis
Reports of nasal blockage, rhinorrhea, aching sinuses
and/or reduced smell for at least 12 weeks during the
last year, occurred with consistently higher frequencies
in subjects with multi-symptom asthma compared with
fewer-symptom asthma and non-asthma (Figure 4). The
distribution of individuals with one or multiple symp-
toms of chronic rhinosinusitis is shown in Figure 5.
When applying a statistical model controlling for nasal
blockage for at least 12 weeks over the last year slightly
reduced the statistical effect of nasal blockage alone on
the risk of having multi-symptom asthma (OR 2.05 ver-
sus 2.68).
Discussion
Multi-symptom asthma is likely to describe a popula-
tion with more severe disease, as night-time awaken-
i n g sd u et oa s t h m aw e r em o r ec o m m o ni nt h i sg r o u p .
In addition, the importance of nasal symptoms as risk-
factors for multi-symptom asthma is highlighted in this
study. Nasal blockage and rhinorrhea, alone and
together with allergic rhinitis, were more frequent in
Table 1 Prevalence (%) of nasal symptoms by asthma population in the West Sweden Asthma Study (18,087
responders)
P-values
Exposure Non- asthma Non asthma vs.
fewer-symptom asthma
Non-asthma vs.
multi-symptom asthma
Fewer-symptom asthma vs.
multi-symptom asthma
n=16,380
Allergic rhinitis 22.9 < 0.001 < 0.001 0.667
Nasal blockage 13.1 < 0.001 < 0.001 < 0.001
Rhinorrhea 11.6 < 0.001 < 0.001 < 0.001
Any of the above 33.3 < 0.001 < 0.001 0.002
All of the above 3.5 < 0.001 < 0.001 < 0.001
3.8% Nasal
blockage
Allergic 
rhinitis 
15.6%
3.1% 
Rhinorrhea
1) 
2.3%
4) 
3.5%
2)      
3.5%
3)
Non-asthma
2.8
%
2.8
%
Allergic 
rhinitis 
38.7%
Rhinorrhea
3)
5.8%
1)8.7%
2) 
4.3%
4)
11.3%
Nasal 
blockage
Fewer-symptom asthma
Allergic 
rhinitis 
25.3%
3.3% Rhinorrhea
1) 11.2%
2)
9.0%
4)
24.8%
3)
4.4%
Multi-symptom asthma
2.8
%
Nasal 
blockage
2.5%
Figure 2 Venn diagram describing the frequency of reported allergic rhinitis, nasal blockage and/or rhinorrhea in the non-asthma,
fewer-symptom asthma and multi-symptom asthma groups. The diagram illustrates that more subjects in the multi-symptom asthma group
have multiple nasal symptoms.
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the number of symptoms of rhinitis and severity of
asthma are closely associated. Furthermore, symptoms
of chronic rhinosinusitis, defined as nasal blockage, rhi-
norrhea, aching sinuses and/or reduced smell for at
least 12 weeks during the last year were closely related
to multi-symptom asthma.
When defining multi-symptom asthma, we included
individuals reporting physician diagnosis of asthma, use
of asthma medication, recurrent wheeze and attacks of
shortness of breath, and one more asthma symptom,
with the aim of identifying those with more intense dis-
ease activity. We suggest that a large component of sub-
jects have a more severe degree of asthma, as they
reported much higher frequency of night-time awaken-
i n g sd u et oa s t h m ac o m p a r e dw i t hn o n - a s t h m aa n d
fewer symptom asthma groups. Furthermore, these sub-
jects may represent a group that are “difficult to treat”,
as they reported several airway symptoms despite having
access to asthma medication as required by the multi-
symptom asthma definition. Defining severe asthma is
not an easy task, as factors such as adherence to treat-
ment, intensity, pathophysiological processes, and the
presence of co-morbid conditions, which are clarified in
an ATS/ERS statement [19] and the paper by Redel et
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Figure 3 Odds ratio of having multi-symptom asthma in
subjects with reported allergic rhinitis, nasal blockage or
rhinorrhea (error bars show 95% confidence intervals). Both
nasal blockage and rhinorrhea increase the risk of having multi-
symptom asthma, however, the presence of allergic rhinitis alone is
not a risk factor for multi-symptom asthma.
Table 2 Risk factors, presented as odds ratios (OR) and 95% confidence intervals (CI) for fewer-symptom asthma and
multi-symptom asthma from a multiple logistic regression analysis of 18,087 responders in the West Sweden Asthma
Study.
Non-asthma vs. fewer-
symptom asthma
Non-asthma vs. multi-
symptom asthma
Fewer-symptom asthma vs. multi-
symptom asthma
Risk factors OR (95% CI) OR (95% CI) OR (95% CI)
Family history +Asthma-Allergy 2.42 (1.93-3.05) 2.44 (1.55-3.84) 1.15 (0.69-1.91)
+Allergy-Asthma 0.97 (0.81-1.15) 1.42 (1.03-1.97) 1.53 (1.05-2.22)
Both 2.39 (2.02-2.82) 3.68 (2.72-4.99) 1.63 (1.16-2.29)
Smoking Ex-smokers 1.41 (1.22-1.63) 1.15 (0.87-1.52) 0.76 (0.56-1.05)
Smokers 1.08 (0.92-1.27) 1.26 (0.96-1.66) 1.28 (0.93-1.77)
Age (years) 31-45 0.91 (0.78-1.07) 0.97 (0.71-1.33) 1.07 (0.75-1.52)
46-60 0.70 (0.59-0.83) 1.16 (0.84-1.59) 1.70 (1.18-2.45)
61-75 0.80 (0.66-0.97) 1.70 (1.21-2.38) 2.08 (1.40-3.09)
Occupational
exposure
1.22 (1.06-1.41) 1.63 (1.28-2.07) 1.36 (1.03-1.80)
Gender Women 1.12 (0.99-1.27) 1.59 (1.26-2.02) 1.31 (1.00-1.72)
Allergic rhinitis 4.98 (4.37-5.68) 3.72 (2.90-4.76) 0.97 (0.73-1.29)
Nasal blockage 1.29 (1.09-1.52) 2.82 (2.15-3.71) 2.21 (1.64-2.97)
Rhinorrhea 1.31 (1.10-1.55) 1.75 (1.32-2.31) 1.49 (1.10-2.02)
All co-variates incorporated in the analysis are presented.
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Figure 4 Frequency of non-asthma, fewer-symptom asthma or multi-symptom asthma in subjects who reported symptoms of chronic
rhinosinusitis, including nasal blockage, nasal secretion, aching sinuses or reduced smell, all for at least 12 weeks during the last
year. Each individual symptom was a significant risk factor for multi-symptom asthma. *** P < 0.001.
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Figure 5 Prevalence of the number of chronic rhinosinusitis symptoms in individuals with no asthma, fewer-symptom asthma, and
multi-symptom asthma. There was a higher frequency of multiple chronic rhinosinusitis symptoms in individuals with multi-symptom asthma.
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Page 6 of 9al. [20], must be considered. In the present study, we
have decided on using the term “multi-symptom
asthma”, as it is clearly definable from an epidemiologi-
cal standpoint. Importantly, no previous attempt has
been made to clearly define a group with more severe
degree of asthma in previous large-scale population
studies, which further illustrates the significance of the
present approach. We suggest that our definition of
multi-symptom asthma is an appropriate epidemiologi-
cal tool to define this group of patients with substan-
tially unmet needs [19].
The prevalence of rhinitis in the general population
from the West Sweden Asthma Study, including
reported allergic rhinitis, nasal blockage and rhinorrhea,
was 37% [21]. However, in both the fewer- and multi-
symptom asthma groups, the prevalence of allergic rhi-
nitis increased to approximately 65%, which is in line
with previous reports [22]. Thus, the presence of allergic
rhinitis was not different between the two groups with
different degree of asthma severity, whereas the pre-
sence of rhinitis is a clear risk factor for having asthma
per se.
Importantly, the prevalence of nasal blockage and rhi-
norrhea was more than twice as high in the multi-symp-
tom asthma population compared with fewer-symptom
asthma, and approximately four times higher in the
multi-symptom asthma population versus the non-
asthma population. It is especially clear that the preva-
lence of several rhinitis symptoms was substantially
higher in the multi-symptom asthma population,
strongly arguing that number of nasal symptoms indeed
is closely related to the severity of asthma, even though
the prevalence of allergic rhinitis per se does not predict
asthma severity. The two strongest risk factors for
multi-symptom asthma versus fewer-symptom asthma
identified in this study were nasal blockage and rhinor-
rhea. This is in agreement with clinically recruited
cohorts [23], reporting that severe rhinitis is often asso-
ciated with more severe asthma. Our study therefore
strengthens these previous findings by confirming the
close association between severity of rhinitis, and sever-
ity of asthma in general, in a random population, and,
in addition, clarifying the true prevalence of these symp-
toms as well as the associations.
As nasal blockage is common in chronic rhinosinusi-
tis, we determined the co-existence of symptoms of this
disease with multi-symptom asthma. Indeed, any sign of
chronic rhinosinusitis, defined as being present for more
than 12 weeks a year, were more frequently reported in
the population with multi-symptom asthma compared
with both the non-asthma and fewer-symptom asthma
groups. Interestingly, more than 60% of subjects with
multi-symptom asthma had at least one sign of chronic
rhinosinusitis, arguing that a close relationship exists
between these conditions. Signs of chronic rhinosinusitis
were also associated with multi-symptom asthma
regardless of whether the individual reported allergic
rhinitis or not, arguing that the allergic status of the
individual may be unimportant for this interaction.
However, clinical studies that investigate the sensitisa-
tion status in patients with signs of chronic rhinosinusi-
tis and multi-symptom asthma are needed to confirm
any such independence. An alternative hypothesis could
be that infectious agents, including both viruses, bacteria
and fungi, could interfere with both nasal symptoms and
the severity of asthma [13].
In addition to the number of nasal symptoms, several
other factors appear to distinguish the multi-symptom
and fewer symptom asthma populations. A family his-
tory of allergy or both allergy and asthma increased the
risk of having multi-symptom disease, although a family
history of asthma did not clearly distinguish the two
categories. In addition, old age, occupational exposure
to gas, dust or fumes, and female gender are related to
multi-symptom asthma, confirming the involvement of
multiple factors for developing a more severe type of
asthma. Previous risk-factor analyses of severe asthma
have seldom been based on random samples, but rather
on clinical cohorts, which lead to substantial selection
bias in the analysis [15].
The strengths of the present study are that it has uti-
lised well-validated epidemiological questionnaires, and it
includes a very large random population, which contri-
butes to high internal validity. The response rate was
similar or higher than some other international studies of
similar nature [24], albeit slightly lower than some other
Swedish studies [25]. Importantly, a survey of those in
the current study who did not respond to the question-
naire revealed no differences in prevalence of respiratory
symptoms between responders and non-responders, and
identical risk-factor profiles [25]. Nevertheless, a relative
weakness of any study using postal questionnaires is that
that all symptoms and diagnoses are self-reported, which
introduces an uncertainty regarding the exact objective
clinical diagnosis in each individual. However, the ques-
tion “have you been told by a doctor that you have
asthma” has proven to have very high specificity in Swed-
ish samples [26]. Importantly, the questions used in this
study about symptoms of chronic rhinosinusitis have
recently been assessed, showing that answers were rea-
sonably stable over time and between countries, were not
influence by the presence of allergic rhinitis, and
appeared suitable to determine prevalence of chronic rhi-
nosinusitis in epidemiology (unpublished results, sub-
mitted for publication). Lastly, understanding and
diagnosing chronic rhinosinusitis remains elusive, as epi-
demiological tools and clinical tools are poorly validated,
and the pathophysiological processes are still poorly
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duals with chronic rhinosinusitis in an epidemiological
setting remains a high priority, and further phenotyping
of these individuals will require detailed clinical investi-
gations, which is beyond the scope of any large epidemio-
logical approach to identify risk factors.
Conclusions
This study describes the close association between the
presence of several nasal symptoms and multi-symptom
asthma, and underlines the difference in risk factor pat-
terns for fewer- or multi symptom asthma. Unlike many
previous studies that have evaluated the relationship
between rhinitis and asthma severity, the present study
is based on a very large, randomly-selected population,
which substantially increases the validity of the results.
Indeed, a large survey, such as the West Sweden
Asthma Study, is required to achieve sufficient power to
identify associations and risk factors in different disease
sub-groups, such as the multi-symptom asthma group.
The observed link between the extent of nasal symp-
toms and the presence of multi-symptom asthma,
further emphasizes the importance that physicians con-
sider the presence of asthma in patients who present
with nasal symptoms, and vice versa.
Abbreviations
OR: odds ratios, 95% CI: 95% confidence interval
Acknowledgements
This study was funded by VBG-GROUP Centre for Asthma and Allergy
Research, Herman Krefting Foundation against Asthma and Allergy, the
Swedish Research Council (K2008-57X-20676-01-3), Swedish Heart and Lung
Foundation (20070560), GA
2LEN network of excellence (EU grant FOOD-CT-
2004-506378).
Authors’ contributions
JL and BL conceived the work; LE performed the analyses. JL and LE wrote
the core of the manuscript. All authors contributed to the discussion. All the
authors read and approved the final manuscript.
Competing interests
Jan Lötvall has received consultancy and speaker fees from AstraZeneca,
GlaxoSmithKline, MSD/Merck, Novartis, and Schering-Plough.
Received: 2 August 2010 Accepted: 26 November 2010
Published: 26 November 2010
References
1. Anderson HR, Gupta R, Strachan DP, Limb ES: 50 years of asthma: UK
trends from 1955 to 2004. Thorax 2007, 62:85-90.
2. Barraclough R, Devereux G, Hendrick DJ, Stenton SC: Apparent but not real
increase in asthma prevalence during the 1990s. Eur Respir J 2002,
20:826-833.
3. Brogger J, Bakke P, Eide GE, Johansen B, Andersen A, Gulsvik A: Long-term
changes in adult asthma prevalence. Eur Respir J 2003, 21:468-472.
4. Ekerljung L, Ronmark E, Larsson K, Sundblad BM, Bjerg A, Ahlstedt S,
Dahlen SE, Lundback B: No further increase of incidence of asthma:
incidence, remission and relapse of adult asthma in Sweden. Respir Med
2008, 102:1730-1736.
5. Pallasaho P, Lundback B, Meren M, Kiviloog J, Loit HM, Larsson K,
Laitinen LA: Prevalence and risk factors for asthma and chronic
bronchitis in the capitals Helsinki, Stockholm, and Tallinn. Respir Med
2002, 96:759-769.
6. Lotvall J, Ekerljung L, Ronmark EP, Wennergren G, Linden A, Ronmark E,
Toren K, Lundback B: West Sweden Asthma Study: prevalence trends
over the last 18 years argues no recent increase in asthma. Respir Res
2009, 10:94.
7. Lundback B: Epidemiology of rhinitis and asthma. Clin Exp Allergy 1998,
28(Suppl 2):3-10.
8. Ronmark E, Andersson C, Nystrom L, Forsberg B, Jarvholm B, Lundback B:
Obesity increases the risk of incident asthma among adults. Eur Respir J
2005, 25:282-288.
9. Kanani AS, Broder I, Greene JM, Tarlo SM: Correlation between nasal
symptoms and asthma severity in patients with atopic and nonatopic
asthma. Ann Allergy Asthma Immunol 2005, 94:341-347.
10. Toren K, Olin AC, Hellgren J, Hermansson BA: Rhinitis increase the risk for
adult-onset asthma–a Swedish population-based case-control study
(MAP-study). Respir Med 2002, 96:635-641.
11. Annesi-Maesano I, Beyer A, Marmouz F, Mathelier-Fusade P, Vervloet D,
Bauchau V: Concurrent allergic diseases: a cross-sectional study in a
French population. Allergy 2006, 61:390-391.
12. Bousquet J, Vignola AM, Demoly P: Links between rhinitis and asthma.
Allergy 2003, 58:691-706.
13. Bresciani M, Paradis L, Des Roches A, Vernhet H, Vachier I, Godard P,
Bousquet J, Chanez P: Rhinosinusitis in severe asthma. J Allergy Clin
Immunol 2001, 107:73-80.
14. Dixon AE, Raymond DM, Suratt BT, Bourassa LM, Irvin CG: Lower airway
disease in asthmatics with and without rhinitis. Lung 2008, 186:361-368.
15. Gaga M, Papageorgiou N, Yiourgioti G, Karydi P, Liapikou A, Bitsakou H,
Zervas E, Koulouris NG, Holgate ST: Risk factors and characteristics
associated with severe and difficult to treat asthma phenotype: an
analysis of the ENFUMOSA group of patients based on the ECRHS
questionnaire. Clin Exp Allergy 2005, 35:954-959.
16. Navarro A, Valero A, Julia B, Quirce S: Coexistence of asthma and allergic
rhinitis in adult patients attending allergy clinics: ONEAIR study. J Investig
Allergol Clin Immunol 2008, 18:233-238.
17. Ronmark EP, Ekerljung L, Lotvall J, Toren K, Ronmark E, Lundback B: Large
scale questionnaire survey on respiratory health in Sweden: effects of
late- and non-response. Respir Med 2009, 103:1807-1815.
18. Lundback B, Nystrom L, Rosenhall L, Stjernberg N: Obstructive lung
disease in northern Sweden: respiratory symptoms assessed in a postal
survey. Eur Respir J 1991, 4:257-266.
19. Chung KF, Godard P, Adelroth E, Ayres J, Barnes N, Barnes P, Bel E,
Burney P, Chanez P, Connett G, et al: Difficult/therapy-resistant asthma:
the need for an integrated approach to define clinical phenotypes,
evaluate risk factors, understand pathophysiology and find novel
therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma.
European Respiratory Society. Eur Respir J 1999, 13:1198-1208.
20. Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW,
Casale TB, Chanez P, Enright PL, Gibson PG, et al: An official American
Thoracic Society/European Respiratory Society statement: asthma
control and exacerbations: standardizing endpoints for clinical asthma
trials and clinical practice. Am J Respir Crit Care Med 2009, 180:59-99.
21. Eriksson J, Ekerljung L, Lotvall J, Pullerits T, Wennergren G, Ronmark E,
Toren K, Lundback B: Growing up on a farm leads to lifelong protection
against allergic rhinitis. Allergy 2010.
22. Leynaert B, Neukirch C, Kony S, Guenegou A, Bousquet J, Aubier M,
Neukirch F: Association between asthma and rhinitis according to atopic
sensitization in a population-based study. J Allergy Clin Immunol 2004,
113:86-93.
23. Ponte EV, Franco R, Nascimento HF, Souza-Machado A, Cunha S,
Barreto ML, Naspitz C, Cruz AA: Lack of control of severe asthma is
associated with co-existence of moderate-to-severe rhinitis. Allergy 2008,
63:564-569.
24. Variations in the prevalence of respiratory symptoms, self-reported
asthma attacks, and use of asthma medication in the European
Community Respiratory Health Survey (ECRHS). Eur Respir J 1996,
9:687-695.
25. Ronmark E, Lundqvist A, Lundback B, Nystrom L: Non-responders to a
postal questionnaire on respiratory symptoms and diseases. Eur J
Epidemiol 1999, 15:293-299.
Lötvall et al. Respiratory Research 2010, 11:163
http://respiratory-research.com/content/11/1/163
Page 8 of 926. Torén K, Brisman J, Järvholm B: Asthma and asthma-like symptoms in
dults assessed by questionnaires. A literature review. Chest 1993,
104:600-8.
27. Baraniuk JN, Maibach H: Pathophysiological classification of chronic
rhinosinusitis. Respir Res 2005, 6:149.
doi:10.1186/1465-9921-11-163
Cite this article as: Lötvall et al.: Multi-symptom asthma is closely
related to nasal blockage, rhinorrhea and symptoms of chronic
rhinosinusitis-evidence from the West Sweden Asthma Study. Respiratory
Research 2010 11:163.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Lötvall et al. Respiratory Research 2010, 11:163
http://respiratory-research.com/content/11/1/163
Page 9 of 9